Clinical and Rehabilitative Management of Retinitis Pigmentosa:Up-to-Date
Open Access
- 1 June 2011
- journal article
- research article
- Published by Bentham Science Publishers Ltd. in Current Genomics
- Vol. 12 (4) , 250-259
Abstract
The term retinitis pigmentosa (RP) indicates a heterogeneous group of genetic rare ocular diseases in which either rods or cones are prevalently damaged. RP represents the most common hereditary cause of blindness in people from 20 to 60 years old. In general, the different RP forms consist of progressive photo-receptorial neuro-degenerations, which are characterized by variable visual disabilities and considerable socio-sanitary burden. Sometimes, RP patients do not become visually impaired or legally blind until their 40-50 years of age and/or maintain a quite acceptable sight for all their life. Other individuals with RP become completely blind very early or in middle childhood. Although there is no treatment that can effectively cure RP, in some case-series the disease's progression seems to be reducible by specific preventive approaches. In the most part of RP patients, the quality of vision can be considerably increased by means of nanometer-controlled filters. In the present review, the main aspects of the routine clinical and rehabilitative managements for RP patients are described, particularly focusing on the importance of specific referral Centers to practice a real multidisciplinary governance of these dramatic diseases.Keywords
This publication has 122 references indexed in Scilit:
- Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector AdministrationMolecular Therapy, 2010
- Retinal light damage: Mechanisms and protectionProgress in Retinal and Eye Research, 2010
- Gene delivery to mitotic and postmitotic photoreceptors Via compacted DNA nanoparticles results in improved phenotype in a mouse model of retinitis pigmentosaThe FASEB Journal, 2009
- Which Leber congenital amaurosis patients are eligible for gene therapy trials?Journal of American Association for Pediatric Ophthalmology and Strabismus, 2009
- Gene therapy for retinitis pigmentosa and Leber congenital amaurosis caused by defects in AIPL1: effective rescue of mouse models of partial and complete Aipl1 deficiency using AAV2/2 and AAV2/8 vectorsHuman Molecular Genetics, 2009
- Safety and Efficacy of Gene Transfer for Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Effect of Gene Therapy on Visual Function in Leber's Congenital AmaurosisNew England Journal of Medicine, 2008
- Long-term visual prognoses in patients with retinitis pigmentosa: The Ludwig von Sallmann lectureExperimental Eye Research, 2007
- Perspective on Genes and Mutations Causing Retinitis PigmentosaArchives of Ophthalmology (1950), 2007
- Violet and blue light blocking intraocular lenses: photoprotection versus photoreceptionBritish Journal of Ophthalmology, 2006